Pictet Asset Management Sa Mersana Therapeutics, Inc. Transaction History

Pictet Asset Management Sa

  • $83.4 Billion
  • Q2 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$5.65 - $7.86 $64,918 - $90,311
11,490 New
11,490 $67,000
Q4 2021

Feb 10, 2022
SELL
$5.48 - $9.86 $12.3 Million - $22.1 Million
-2,237,868 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$8.56 - $14.47 $19.2 Million - $32.4 Million
2,237,868 New
2,237,868 $21.1 Million

Others Institutions Holding MRSN

# of Institutions
130
Shares Held
104M
Call Options Held
58.5K
Put Options Held
471K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $56.4M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email